Recruiting Essential Tremor Studies in Arcadia
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
This study is open to adults 18 and older with an eye condition called diabetic macular edema. People are required to have a specific type of diabetic macular edema called centre-involved diabetic mac...
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME....
About Essential Tremor Clinical Trials in Arcadia
Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.
There are currently 2 essential tremor clinical trials recruiting participants in Arcadia, CALIFORNIA. These studies are seeking a combined 450 participants. Research is being sponsored by Boehringer Ingelheim, Kyowa Kirin Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Essential Tremor Clinical Trials in Arcadia — FAQ
Are there essential tremor clinical trials in Arcadia?
Yes, there are 2 essential tremor clinical trials currently recruiting in Arcadia, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Arcadia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Arcadia research site will contact you about next steps.
Are clinical trials in Arcadia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Arcadia studies also compensate for your time and travel.
What essential tremor treatments are being tested?
The 2 active trials in Arcadia are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.
Data updated March 2, 2026 from ClinicalTrials.gov